More recently, in December, the FDA approved semaglutide for weight loss in adolescents aged 12 to 17 years with an initial BMI in the 95th percentile for age and sex
During this session, our expert team will: Evaluate Your Health: This process will thoroughly assess your medical history, present state of health, and weight loss objectives
Discuss benefits and risks with your provider before starting treatment
With his experience in both general and minimally invasive surgery, patients benefit from accurate diagnoses, minimal downtime, and compassionate care
A 2023 systematic review and meta-analysis published in the Journal of Clinical Medicine found that semaglutide reduced systolic blood pressure by approximately 5 mmHg and diastolic blood pressure by about 2.5 mmHg in patients without diabetes
Ozempic is approved for type 2 diabetes glycemic control (2017), cardiovascular risk reduction in T2D (2020), and CKD progression in T2D (February 2026)